Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H16O8 |
Molecular Weight | 360.3148 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(=CC(O)=C1OC)C2=COC3=C(C2=O)C(O)=C(OC)C(O)=C3
InChI
InChIKey=TUGWPJJTQNLKCL-UHFFFAOYSA-N
InChI=1S/C18H16O8/c1-23-13-5-8(4-10(19)17(13)24-2)9-7-26-12-6-11(20)18(25-3)16(22)14(12)15(9)21/h4-7,19-20,22H,1-3H3
Irigenin is an O-methylated isoflavone. It can be isolated from the rhizomes of the leopard lily (Belamcanda chinensis), and Iris Kemaonensis; which are used in traditional Chinese and Tibetan medicine. Irigenin has been identified as a potential anti-inflammatory compound; reducing inflammatory Nitric Oxide and Prostaglandin production. Irigenin has also been investigated in cell models for lung cancer.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0002537 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16307761 |
|||
Target ID: GO:0002539 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16307761 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Alkylated benzoquinones from Iris kumaonensis. | 2002 Dec |
|
Analysis of DNA in endometrial cancer cells treated with phyto-estrogenic compounds using comparative genomic hybridisation microarrays. | 2005 May |
|
Isolation and purification of isoflavonoids from Rhizoma Belamcandae by two-dimensional preparative high-performance liquid chromatography with column switch technology. | 2009 Oct |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22071270
In a pharmacokinetic study, rats were orally dosed with 50 mg/kg bw of extract from Rhizoma Belamcandae; which corresponds to 27.0 mg/kg of irigenin. A maximum plasma concentration (405.08 ng/mL) of Irigenin was achieved within half an hour, suggesting rapid absorption through the stomach.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16307761
RAW 264.7 cells were transfected wit hpNF-kB-SEAP-NPT plasmid to introduce the SEAP reporter gene for NF-kB activity. Irigenin was isolated from extracts of the rhizomes of B. chinensis. Cells were stimulated with 100 ng/mL of lipopolysaccharide (LPS) for 18 hours to induce iNOS. Irigenin was then added to cell cultures in doses of 3, 10, or 30 microM. After 18 hours of Irigenine treatment, cultures were assayed (using the Griess Method) for effects on Nitrous Oxide production, PGE2 production, and iNOS enzyme activity. Irigenin significantly reduced NO production and PGE2 production. Furthermore, Irigenin inhibited the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COS-2) and mRNAs without appreciable cytotoxic effects. Irigenin also appears to have lowered the NF-kB activity in the cells, as measured by electrophoretic mobility shift assay. These results suggest that Irrigenin may be interesting as an anti-inflammatory molecule.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m6404
Created by
admin on Fri Dec 15 19:40:00 GMT 2023 , Edited by admin on Fri Dec 15 19:40:00 GMT 2023
|
PRIMARY | Merck Index | ||
|
Irigenin
Created by
admin on Fri Dec 15 19:40:00 GMT 2023 , Edited by admin on Fri Dec 15 19:40:00 GMT 2023
|
PRIMARY | |||
|
C509874
Created by
admin on Fri Dec 15 19:40:00 GMT 2023 , Edited by admin on Fri Dec 15 19:40:00 GMT 2023
|
PRIMARY | |||
|
5464170
Created by
admin on Fri Dec 15 19:40:00 GMT 2023 , Edited by admin on Fri Dec 15 19:40:00 GMT 2023
|
PRIMARY | |||
|
6O4NX37350
Created by
admin on Fri Dec 15 19:40:00 GMT 2023 , Edited by admin on Fri Dec 15 19:40:00 GMT 2023
|
PRIMARY | |||
|
208-958-3
Created by
admin on Fri Dec 15 19:40:00 GMT 2023 , Edited by admin on Fri Dec 15 19:40:00 GMT 2023
|
PRIMARY | |||
|
548-76-5
Created by
admin on Fri Dec 15 19:40:00 GMT 2023 , Edited by admin on Fri Dec 15 19:40:00 GMT 2023
|
PRIMARY | |||
|
DTXSID90203285
Created by
admin on Fri Dec 15 19:40:00 GMT 2023 , Edited by admin on Fri Dec 15 19:40:00 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD